Lupin Q3 results: Net jumps 300% to Rs 613 cr on back of record sales
North America sales for Q3 FY 2024 were Rs 1,888.5 crore, up 23.7 per cent Y-o-Y. North America accounted for
Continue reading
Tag: nifty pharma
The Number One Finance & Business Blog!